Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Issue of Equity

2 Sep 2020 16:55

RNS Number : 8673X
Amati AIM VCT PLC
02 September 2020
 

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

 

Offer for Subscription of New Shares (the "Offer")

 

Amati AIM VCT plc announces an allotment on 2 September 2020 of 1,302,652 New Shares pursuant to the Offer. In accordance with the Terms and Conditions of the Offer, the Offer Price at which new ordinary shares were allotted, which was calculated by reference to the net asset value of an ordinary share on 31 August 2020, was 172.65p per ordinary share (net asset value divided by 0.99 to allow for issue costs of 1.0%).

 

Following the allotment above, the total number of ordinary shares in issue is 106,653,900 with each ordinary share carrying one voting right. That figure may be used by shareholders as the denominator for the calculation to determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

 

Applications have been made for the New Shares to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for admission to trading on the Main Market. It is expected that admission will occur and dealing will commence in the New Shares to be issued pursuant to the Offer on or around 8 September 2020. CREST accounts are expected to be credited within five business days of allotment and definitive documents of title are expected to be dispatched within ten business days of allotment.

 

Terms defined in the Prospectus published by the Company on 31 October 2019 have the same meanings in this announcement unless the context requires otherwise.

 

 

 

For further information please email info@amatiglobal.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEKKBBPPBKDNCK
Date   Source Headline
10th Apr 20188:14 amRNSDirector/PDMR Shareholding
9th Apr 20185:19 pmRNSIssue of Equity
4th Apr 20185:10 pmRNSNet Asset Value(s)
4th Apr 201811:21 amRNSCompliance with Market Abuse Regulation
3rd Apr 20189:38 amRNSTotal Voting Rights
29th Mar 20182:29 pmRNSTransaction in Own Shares
27th Mar 20183:49 pmRNSIssue of Equity
26th Mar 201811:41 amRNSNet Asset Value(s)
23rd Mar 20185:45 pmRNSTransaction in Own Shares
20th Mar 20185:23 pmRNSIssue of Equity
19th Mar 20183:15 pmRNSNet Asset Value(s)
19th Mar 20181:31 pmRNSHolding(s) in Company
13th Mar 20182:30 pmRNSTransaction in Own Shares
12th Mar 20183:07 pmRNSNet Asset Value(s)
9th Mar 20185:47 pmRNSIssue of a Supplementary Prospectus and Circular
2nd Mar 20185:03 pmRNSNet Asset Value(s)
1st Mar 201810:07 amRNSTotal Voting Rights
28th Feb 20188:02 amRNSIssue of Equity - replacement
27th Feb 20183:45 pmRNSDirector/PDMR Shareholding
27th Feb 20183:39 pmRNSIssue of Equity
26th Feb 20183:11 pmRNSNet Asset Value(s)
23rd Feb 20183:39 pmRNSTransaction in Own Shares
20th Feb 201811:00 amRNSNet Asset Value(s)
15th Feb 20182:02 pmRNSTransaction in Own Shares
12th Feb 20184:27 pmRNSNet Asset Value(s)
5th Feb 20181:46 pmRNSTransaction in Own Shares
2nd Feb 20182:38 pmRNSNet Asset Value(s)
1st Feb 20188:10 amRNSTotal Voting Rights
31st Jan 201810:07 amRNSDirector/PDMR Shareholding
30th Jan 20185:11 pmRNSIssue of Equity
29th Jan 20185:01 pmRNSNet Asset Value(s)
22nd Jan 20185:07 pmRNSNet Asset Value(s)
22nd Jan 201811:16 amRNSTransaction in Own Shares
19th Jan 201811:38 amRNSTransaction in Own Shares
18th Jan 201810:07 amRNSDirector Declaration
15th Jan 20184:53 pmRNSNet Asset Value(s)
4th Jan 20183:20 pmRNSNet Asset Value(s)
3rd Jan 20187:29 amRNSTotal Voting Rights
28th Dec 201710:26 amRNSTransaction in Own Shares
27th Dec 20177:00 amRNSNet Asset Value(s)
19th Dec 20174:39 pmRNSIssue of Equity
18th Dec 20174:15 pmRNSNet Asset Value(s)
18th Dec 201710:14 amRNSTransaction in Own Shares
11th Dec 20175:31 pmRNSNet Asset Value(s)
8th Dec 201712:25 pmRNSTransaction in Own Shares
6th Dec 201710:27 amRNSHolding(s) in Company
4th Dec 20174:22 pmRNSNet Asset Value(s)
1st Dec 20175:05 pmRNSTransaction in Own Shares
1st Dec 20179:27 amRNSTotal Voting Rights
29th Nov 201711:30 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.